Holson; Edward B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Holson; Edward B..The latest application filed is for "compounds and methods for inhibiting the interaction of bcl proteins with binding partners".

Company Profile

0.14.13

Holson; Edward B. - Newton Highlands MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,609,706 - Castro , et al. December 17, 2	2013-12-17
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,461,191 - Castro , et al. June 11, 2	2013-06-11
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20130131063 - Castro; Alfredo C. ; et al.	2013-05-23
Ansamycin formulations and methods of use thereof Grant 8,357,676 - Austad , et al. January 22, 2	2013-01-22
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,304,428 - Castro , et al. November 6, 2	2012-11-06
Ansamycin formulations and methods of use thereof Grant 8,283,343 - Austad , et al. October 9, 2	2012-10-09
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 8,178,690 - Castro , et al. May 15, 2	2012-05-15
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20110213145 - Castro; Alfredo C. ; et al.	2011-09-01
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20110160259 - Castro; Alfredo C. ; et al.	2011-06-30
Ansamycin formulations and methods of use thereof Grant 7,947,670 - Austad , et al. May 24, 2	2011-05-24
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 7,928,244 - Castro , et al. April 19, 2	2011-04-19
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 7,851,637 - Castro , et al. December 14, 2	2010-12-14
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 7,842,815 - Castro , et al. November 30, 2	2010-11-30
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20100190791 - CASTRO; ALFREDO C. ; et al.	2010-07-29
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Grant 7,745,464 - Castro , et al. June 29, 2	2010-06-29
Ansamycin formulations and methods of use thereof App 20090069281 - Austad; Brian C. ; et al.	2009-03-12
Ansamycin formulations and methods of use thereof App 20090062528 - Austad; Brian C. ; et al.	2009-03-05
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners App 20080306127 - Castro; Alfredo C. ; et al.	2008-12-11
Ansamycin formulations and methods of use thereof App 20080221077 - Austad; Brian C. ; et al.	2008-09-11
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners App 20080114167 - CASTRO; Alfredo C. ; et al.	2008-05-15
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners App 20070161690 - Castro; Alfredo C. ; et al.	2007-07-12
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners App 20070155705 - Castro; Alfredo C. ; et al.	2007-07-05
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners App 20060025460 - Castro; Alfredo C. ; et al.	2006-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.